Ask AI
ProCE Banner Activity

How Do CELMoDs Work for Multiple Myeloma?

Clinical Thought

In this brief commentary derived from a recent symposium at the European Hematology Association 2025 Congress, experts discuss the mechanism of action of CELMoDs in multiple myeloma and possible use in the clinic.

Released: August 13, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb

Disclosure

Primary Author

Michele Cavo, MD, has no relevant financial relationships to disclose.

Sagar Lonial, MD, FACP: consultant/advisor/speaker: AbbVie, Amgen, Bristol Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Novartis, Pfizer, Regeneron, Takeda; researcher: Bristol Myers Squibb, Janssen, Novartis, Takeda; other financial or material support: TG Therapeutics.

Charlotte Pawlyn, MB BChir, PhD: consultant/advisor/speaker: AbbVie, Amgen, Bristol Myers Squibb/Celgene, GlaxoSmithKline, Johnson & Johnson, Menarini, Opna Bio, Pfizer, Sanofi; researcher: Johnson & Johnson.